Neovaginal Surgery Market Size, Share & Trends Analysis Report By Treatment Type (Vaginal Agenesis Treatment Surgery, Vaginal Atresia Treatment Surgery, Sex Reassignment Surgery), By Region, And Segment Forecasts, 2024 - 2030

Neovaginal Surgery Market Size & Trends

The global neovaginal surgery market size was estimated at USD 1.20 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 5.04% from 2024 to 2030. The market expansion can be attributed to various factors, including the availability of insurance and a notable rise in the number of gender confirmation surgeries. Insurance companies from various regions offer adequate health coverage for Sex Reassignment Surgery (SRS). For instance, the Health Insurance Fund of Australia (HIF) includes insurance coverage for SRS, such as neovaginal surgery. Additionally, there has been a gradual increase in access to gender confirmation procedures as well as social acceptance of transgender individuals in the past few years, which is expected to help the market expand further.

Developing countries, such as India, also provide financial assistance to individuals seeking such surgeries. Owing to the increasing demand, service providers are taking initiatives to increase their geographic reach to cater to increased patient inflow. In August 2022, the National Health Authority (NHA) under the Ministry of Health and Family Welfare of India and the Department of Social Justice and Empowerment signed an MoU to offer a composite and inclusive health package for transgender people under Ayushman Bharat-PMJAY. The package includes funding of USD 0.63 million (around INR 5 lakh) per transgender, which includes specific packages like Sex Reassignment Surgery (SRS) and treatment, along with the existing Ayushman Bharat-PMJAY.

COVID-19 posed significant challenges for healthcare providers and patients seeking various medical services, exacerbating existing shortages in skilled healthcare professionals for treatments such as hormone interventions, gender-affirming surgeries, and vaginoplasty. As the pandemic unfolded, many hospitals chose to delay or cancel elective procedures, including gender-affirming surgeries, to preserve critical resources. Post-pandemic, gynecology departments and cosmetic clinics gradually resumed offering both cosmetic and essential treatments while actively assisting foreign patients in meeting the Ministry of Public Health and Ministry of Foreign Affairs' requirements, including a mandatory 14-day quarantine, travel insurance with a minimum USD 100,000 COVID-19 treatment coverage, and a pre-flight COVID-19 test within 72 hours when traveling to these countries.

Treatment Type Insights

Based on the treatment type, the market is segmented into vaginal agenesis treatment surgery, vaginal atresia treatment surgery, and sex reassignment surgery. The sex reassignment surgery (SRS) segment held the largest revenue share of 55.4% in 2023 and is further expected to advance at the fastest CAGR during the projection period. The segment expansion is on account of the growing demand for Male-to-Female (MtF) surgeries worldwide. Several factors, including rising demand and reimbursement policies, are aiding the segment's expansion.

Historically, Medicare did not cover cosmetic surgeries or gender reassignment procedures. In December 2022, on account of the rising demand for sex reassignment surgeries, several insurance providers updated their policies to enable coverage for these procedures. Neovaginal surgery is especially relevant for individuals facing a rare congenital disability known as vaginal agenesis, which occurs in approximately 1 out of every 5,000 women. Various surgical techniques, including the Davydov procedure and sigmoid vaginoplasty, create a neovagina in patients with this condition. Sigmoid vaginoplasty in particular is considered to be efficient and suitable for medical facilities that have limited resources.

Regional Insights

Asia Pacific dominated the market with a share of 50.47% in 2023. A major factor contributing to the growth of this region is witnessing increased awareness regarding the availability of neovaginal surgeries. Few destinations witness an increased influx of foreign patients due to factors such as the availability of treatments at low cost. Asia Pacific is expected to advance substantially during the forecast period. Rising demand for gender reassignment surgeries among the Asian transgender population is poised to enhance the growth of the regional neovaginal surgery industry. Key Asian markets, such as Thailand, Indonesia, and Japan, have liberal regulations for neovaginal surgical procedures.

North America is well-regulated for cosmetic treatments. The convenient availability of insurance coverage along with the growing number of medical practitioners specializing in the treatment of vaginal anomalies are leading factors contributing to the rising regional adoption of neovaginal surgical procedures. Also, rising awareness about gender-affirming surgeries in the U.S. has resulted in an increase in the number of people opting for laparoscopic neovaginal surgical procedures to reassign their gender according to their preferences.

Europe is anticipated to experience significant growth over the forecast period. This growth is attributed to the increasing social awareness and greater acceptance of gender reassignment in most European countries. Consequently, there has been a notable rise in the number of surgical procedures and techniques, driving the demand for products like dilators, vaginal stents, and laparoscopic neovaginal surgery kits used in these procedures. These products boast unique features, including the capability to be heated or cooled before use and vibration, which has been instrumental in boosting market demand among European consumers and contributing to the region's overall revenue.

Key Companies & Market Share Insights

The market is fragmented with many multinational and regional players offering various services. Key service providers are adopting expansion strategies to enhance their services. In February 2020, Karl Storz, in association with VirtaMed, a provider of medical training simulation, introduced a mixed reality simulator, LapTrainer, to provide training in laparoscopy. The simulator enables medical professionals to acquire key skills by repeating short simulation sequences and practicing patient positioning.

Neovaginal Surgery Market Report Scope

Global Neovaginal Surgery Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global neovaginal surgery market report based on treatment type and region:

• Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Vaginal Agenesis Treatment Surgery

  • Vaginal Atresia Treatment Surgery

    • McIndoe Technique

    • Vecchietti Technique

  • Sex Reassignment Surgery

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • Indonesia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait